Combining Complementary Biophysical & Structural Approaches to Build Confidence in Drug Discovery Decisions for Complex Target Classes

2:00 pm - Wednesday 13th January 2027

  • Understand how native mass spectrometry can reveal biologically relevant protein conformations and interactions that are difficult to capture using a single technique
  • Learn how to integrate structural biology, biophysics, and high-resolution structural data to generate actionable hypotheses for hit identification and optimisation
  • Explore case studies from challenging target classes, including the TNF superfamily, where combining orthogonal technologies enabled tractable drug discovery strategies

Speakers:

Founder & Vice President - Platforms
OMass Therapeutics